Sally C. Medley

Array ( [id] => 3528478 [patent_doc_number] => 05541293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Consensus human leukocyte interferon' [patent_app_type] => 1 [patent_app_number] => 7/472328 [patent_app_country] => US [patent_app_date] => 1990-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16038 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541293.pdf [firstpage_image] =>[orig_patent_app_number] => 472328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3072074 [patent_doc_number] => 05364837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-15 [patent_title] => 'Method of modifying serum hormone levels using purified inhibin materials' [patent_app_type] => 1 [patent_app_number] => 7/389328 [patent_app_country] => US [patent_app_date] => 1989-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5575 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/364/05364837.pdf [firstpage_image] =>[orig_patent_app_number] => 389328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2462512 [patent_doc_number] => 04844893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-04 [patent_title] => 'EX vivo effector cell activation for target cell killing' [patent_app_type] => 1 [patent_app_number] => 6/916173 [patent_app_country] => US [patent_app_date] => 1986-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/844/04844893.pdf [firstpage_image] =>[orig_patent_app_number] => 916173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3459603 [patent_doc_number] => 05391485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues' [patent_app_type] => 1 [patent_app_number] => 6/763130 [patent_app_country] => US [patent_app_date] => 1985-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9005 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391485.pdf [firstpage_image] =>[orig_patent_app_number] => 763130 [rel_patent_id] =>[rel_patent_doc_number] =>)